Bioimpedance Evaluation of Therapeutic Titration in Essential, Refractory Hypertension

Status unconfirmed

Conditions studied: Hypertension

In brief

To determine whether impedance cardiography (ICG) parameters can predict favorable or unfavorable blood pressure (BP) response and time to BP control prior to initiation or intensification of specific antihypertensive drug classes and drug combinations, independent of initial BP levels.

Key facts

Study ID

NCT00913094

Run by

CardioDynamics

People needed

200

Starts

2009-01-01

Expected to finish

2011-06-01

Last updated by the study team

2009-06-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• > 18 years of age
• Able to provide written consent
• Meet JNC definition of hypertension
• Lab results with 6 months for: serum creatinine, urine albumin/creatinine ratio, and at least one of the following: serum glucose, or glycated hemoglobin, or hemoglobin A1C

You may not qualify if…

• Active cardiovascular disease (unstable angina, stage C or D heart failure, uncontrolled superventricular arrhythmia, hx of ventricular arrhythmia, stroke or TIA within 6 months, ACS within 6 months)
• Implantation of activated ventricular pacemaker
• Known hypersensitivity or allergy to sensor gel or adhesives
• Skin lesions prohibiting sensor placement

Where it is running

• Wayne State University — Detroit, Michigan, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.